Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (RBR-2j24fkk) titled 'Effectiveness of Arginine supplementation in aiding the treatment of Sickle Cell Anemia' on Aug. 12.
Study Type: Intervention
Primary Sponsor: Secretaria da Saude do Estado do Ceara
Condition:
Anemia, Sickle Cell
Intervention:
This is a randomized, double-blind, placebo-controlled clinical study with two arms. Study group: 50 patients with Sickle Cell Anemia using Hydroxyurea (dose greater than or equal to 500 mg per day) will supplement with L-arginine (500 mg per day). Placebo group: 50 patients with Sickle Cell Anemia using Hydroxyurea (greater than or equal to 500 mg per day) will receive placebo (starch). Pa...